Substrate shape determines specificity of recognition for HIV-1 protease: Analysis of crystal structures of six substrate complexes

被引:258
作者
Prabu-Jeyabalan, M [1 ]
Nalivaika, E [1 ]
Schiffer, CA [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0969-2126(02)00720-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The homodimeric HIV-1 protease is the target of some of the most effective antiviral AIDS therapy, as it facilitates viral maturation by cleaving ten asymmetric and nonhomologous sequences in the Gag and Pol poly-proteins. Since the specificity of this enzyme is not easily determined from the sequences of these cleavage sites alone, we solved the crystal structures of complexes of an inactive variant (D25N) of HIV-1 protease with six peptides that correspond to the natural substrate cleavage sites. When the protease binds to its substrate and buries nearly 1000 Angstrom(2) of surface area, the symmetry of the protease is broken, yet most internal hydrogen bonds and waters are conserved. However, no substrate side chain hydrogen bond is conserved. Specificity of HIV-1 protease appears to be determined by an asymmetric shape rather than a particular amino acid sequence.
引用
收藏
页码:369 / 381
页数:13
相关论文
共 66 条
[21]   ACTIVE HUMAN IMMUNODEFICIENCY VIRUS PROTEASE IS REQUIRED FOR VIRAL INFECTIVITY [J].
KOHL, NE ;
EMINI, EA ;
SCHLEIF, WA ;
DAVIS, LJ ;
HEIMBACH, JC ;
DIXON, RAF ;
SCOLNICK, EM ;
SIGAL, IS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4686-4690
[22]   Crystal structures of the inactive D30N mutant of feline immunodeficiency virus protease complexed with a substrate and an inhibitor [J].
Laco, GS ;
SchalkHihi, C ;
Lubkowski, J ;
Morris, G ;
Zdanov, A ;
Olson, A ;
Elder, JH ;
Wlodawer, A ;
Gustchina, A .
BIOCHEMISTRY, 1997, 36 (35) :10696-10708
[23]  
Larder BA, 1995, J ACQ IMMUN DEF SYND, V10, pS28
[24]   PROCHECK - A PROGRAM TO CHECK THE STEREOCHEMICAL QUALITY OF PROTEIN STRUCTURES [J].
LASKOWSKI, RA ;
MACARTHUR, MW ;
MOSS, DS ;
THORNTON, JM .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1993, 26 :283-291
[25]   SHAPE COMPLEMENTARITY AT PROTEIN-PROTEIN INTERFACES [J].
LAWRENCE, MC ;
COLMAN, PM .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 234 (04) :946-950
[26]   INTERPRETATION OF PROTEIN STRUCTURES - ESTIMATION OF STATIC ACCESSIBILITY [J].
LEE, B ;
RICHARDS, FM .
JOURNAL OF MOLECULAR BIOLOGY, 1971, 55 (03) :379-&
[27]   Prevention and treatment of pediatric HIV infection [J].
Luzuriaga, K ;
Sullivan, JL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01) :17-18
[28]   Structural and kinetic analysis of drug resistant mutants of HIV-1 protease [J].
Mahalingam, B ;
Louis, JM ;
Reed, CC ;
Adomat, JM ;
Krouse, J ;
Wang, YF ;
Harrison, RW ;
Weber, IT .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 263 (01) :238-245
[29]   Structural implications of drug-resistant mutants of HIV-1 protease: High-resolution crystal structures of the mutant protease/substrate analogue complexes [J].
Mahalingam, B ;
Louis, JM ;
Hung, J ;
Harrison, RW ;
Weber, IT .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 2001, 43 (04) :455-464
[30]   Molecular recognition of macrocyclic peptidomimetic inhibitors by HIV-1 protease [J].
Martin, JL ;
Begun, J ;
Schindeler, A ;
Wickramasinghe, WA ;
Alewood, D ;
Alewood, PF ;
Bergman, DA ;
Brinkworth, RI ;
Abbenante, G ;
March, DR ;
Reid, RC ;
Fairlie, DP .
BIOCHEMISTRY, 1999, 38 (25) :7978-7988